Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2

The development of effective antiviral drugs against SARS-CoV-2 is urgently needed and a global health priority. In light of the initial data regarding the repurposing of hydroxychloroquine (HCQ) to tackle this coronavirus, herein we present a quantitative synthesis and spectroscopic and thermal cha...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Francisco Faísca, Vanessa Correia, Željko Petrovski, Luís C. Branco, Helena Rebelo-de-Andrade, Miguel M. Santos
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-04-01
coleção:	Pharmaceutics
Assuntos:	API-ILs COVID-19 hydroxychloroquine pharmaceutical ionic liquids SARS-CoV-2
Acesso em linha:	https://www.mdpi.com/1999-4923/14/4/877
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!